Lisa Miller‐Phillips

FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · British Journal of Cancer · 2020 · 177 citations · Full text

Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study

Sebastian Stintzing, Lisa Miller‐Phillips, Dominik Paul Modest et al. · European Journal of Cancer · 2017 · 138 citations

First-line Efficacy, Cetuximab Versus Folfiri, Ras Mutations +11

PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer

Gilles Rademaker, Grace A. Hernandez, Yurim Seo et al. · Nature · 2025 · 21 citations

Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study

Stephan Krüger, A. Lohneis, Annalena Abendroth et al. · ESMO Open · 2022 · 20 citations · Full text

Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial

Julian Walter Holch, Ingrid Ricard, Sebastian Stintzing et al. · International Journal of Cancer · 2017 · 14 citations · Full text